Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Highland Pharmaceuticals
Pharma
Highland Therapeutics launches Phase II testing of nighttime ADHD drug
Highland Therapeutics, a Toronto-based company with delayed-release technology for ADHD treatment, is launching a Phase II study of its drug HLD100 designed for nighttime dosing of ADHD patients to improve their functioning when they wake.
Joseph Keenan
Aug 30, 2016 8:29am
Phase III testing data looks promising for Highland's ADHD drug Benjorna
Apr 13, 2016 4:19pm